SOLUTIONS

Multilex Clinical Modules

Select a Screening & Detection Module:

Drug-Food Interaction Module™

Identifying and preventing significant drug-food interactions.

The Drug-Food Interaction Module alerts clinicians of potential interactions that may occur between certain drugs and foods and provides the capability of generating precautions or other advisory specific to each potential drug-food interaction. The results support a two-line message intended for prescription label printing, as well as access to the appropriate full-text monographs.

FDB Drug Food Interaction Module Advantages:

  • Provides clinically-relevant drug-food interaction information to patients and caregivers. This is recognized as a community practice standard, and required by The Joint Commission.
  • Provides cautions and other advisory information specific to the potential drug-food interaction detected. Alerts and other messages are presented only for clinically significant drug-food combinations, thus avoiding message overload.
  • Provides inclusion criteria for drug-food interactions that relate to severity, documentation and the complexity of patient management.
  • Provides additional information needed by clinicians to manage complex and potentially severe drug-food interactions (for example, CYP3A4 inhibition by grapefruit constituents). These interactions generally require some patient monitoring, if not proactive dose adjustments, recommended in the module.
  • Determines severity level of drug-food interaction it encounters. It can then produce condensed text messages and complete monograph information on the nature of the interaction. These results can generate a two-line message intended for prescription label printing, as well as access to the appropriate monographs.
  • A consumer version of this module, Drug-Food Interactions for Consumers, is also available.